Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 18.838\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) Cc1cc(C)c(NC(=O)CS(=O)CC(=O)Nc2ccc(-n3cnnn3)c(C)c2)c(C)c1
b) Cn1c(N)c(C(=O)COC(=O)c2cc(-c3ccccc3)nc3ccccc23)c(=O)n(C)c1=O
c) C[C@H](NC(=O)COc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
d) COc1ccc(-n2nc(C)cc2N)cc1
Answer: c. C[C@H](NC(=O)COc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C[C@H](NC(=O)COc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
C[C@H](NC(=O)COc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
2-(4-chlorophenoxy)-N-[(2S)-1-oxo-1-spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,4'-piperidine]-1'-ylpropan-2-yl]acetamide